{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:16:19Z","timestamp":1790172979041,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.jbspin.2019.09.015","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T11:39:00Z","timestamp":1569584340000},"page":"293-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Systemic sclerosis: Recent insight in clinical management"],"prefix":"10.1016","volume":"87","author":[{"given":"Elisabetta","family":"Zanatta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Codullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Avouac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2019.09.015_bib0395","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative","volume":"65","author":"Van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0400","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/rheumatology\/keu530","article-title":"Performance of the new ACR\/EULAR classification criteria for systemic sclerosis in clinical practice","volume":"54","author":"Jordan","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0405","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1093\/rheumatology\/kew298","article-title":"Survival and organ involvement in patients with limited cutaneous systemic sclerosis and anti-topoisomerase-I antibodies: determined by skin subtype or auto-antibody subtype? A long-term follow-up study","volume":"55","author":"Kranenburg","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0410","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/art.40906","article-title":"Phenotypes determined by cluster analysis and their survival in the prospective European Scleroderma and Research cohort of patients with systemic sclerosis","volume":"71","author":"Sobanski","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0415","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0420","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/art.40027","article-title":"Early mortality in a multinational systemic sclerosis inception cohort","volume":"69","author":"Hao","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0425","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.chest.2018.05.002","article-title":"Long-term outcomes in systemic sclerosis-associated pulmonary arterial hypertension from the pulmonary hypertension assessment and recognition of outcomes in Scleroderma Registry (PHAROS)","volume":"154","author":"Kolstad","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0430","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3899\/jrheum.160817","article-title":"Malignancies in patients with anti-RNA polymerase III antibodies and systemic sclerosis: analysis of the EULAR scleroderma trials and research cohort and possible recommendations for screening","volume":"44","author":"Lazzaroni","year":"2017","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0435","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/art.40377","article-title":"Review: defining a unified vascular phenotype in systemic sclerosis","volume":"70","author":"Allanore","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0440","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.autrev.2018.09.002","article-title":"Nailfold avascular score and coronary microvascular dysfunction in systemic sclerosis: a newsworthy association","volume":"18","author":"Zanatta","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0445","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.semarthrit.2017.02.006","article-title":"Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis","volume":"47","author":"Avouac","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0450","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/annrheumdis-2014-205897","article-title":"Digital ulcers predict a worse disease course in patients with systemic sclerosis","volume":"75","author":"Mihai","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0455","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/annrheumdis-2016-209481","article-title":"Clinical characteristics and predictors of gangrene in patients with systemic sclerosis and digital ulcers in the Digital Ulcer Outcome Registry: a prospective, observational cohort","volume":"75","author":"Allanore","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0460","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1001\/jama.2016.5258","article-title":"Effect of Macitentan on the development of new ischemic digital ulcers in patients with systemic sclerosis: DUAL-1 and DUAL-2 randomized clinical trials","volume":"315","author":"Khanna","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0465","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0470","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/annrheumdis-2014-207001","article-title":"Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study","volume":"75","author":"Hachulla","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0475","article-title":"Worldwide expert agreement on updated recommendations for the treatment of systemic sclerosis","author":"De Vries-Bouwstra","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0480","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1002\/art.40242","article-title":"Efficacy and safety of selexipag in adults With Raynaud's phenomenon secondary to systemic sclerosis: a randomized, placebo-controlled, phase II study","volume":"69","author":"Denton","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0485","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.semarthrit.2018.03.019","article-title":"Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: systematic literature review and expert consensus","volume":"48","author":"Ingegnoli","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0490","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR scleroderma trials and research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0495","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.autrev.2018.03.012","article-title":"Therapy of scleroderma renal crisis: state of the art","volume":"17","author":"Zanatta","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0500","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/rheumatology\/kex435","article-title":"Frequencies of borderline pulmonary hypertension before and after the DETECT algorithm: results from a prospective systemic sclerosis cohort","volume":"57","author":"Hoffmann-Vold","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0505","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/art.37838","article-title":"Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension","volume":"65","author":"Valerio","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0510","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"24","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0515","doi-asserted-by":"crossref","first-page":"e0197112","DOI":"10.1371\/journal.pone.0197112","article-title":"Clinical phenotypes and survival of pre-capillary pulmonary hypertension in systemic sclerosis","volume":"13","author":"Launay","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0520","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0525","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/art.40862","article-title":"Prevalence, treatment and outcomes of coexistent pulmonary hypertension and interstitial lung disease in systemic sclerosis","volume":"718","author":"Young","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0530","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1183\/13993003.00395-2016","article-title":"Sildenafil for pulmonary hypertension complicating idiopathic pulmonary fibrosis: a rationale grounded in basic science","volume":"47","author":"Hassoun","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0535","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018816089","article-title":"Hemodynamic changes after acute fluid loading in patients with systemic sclerosis without pulmonary hypertension","volume":"9","author":"D\u2019Alto","year":"2019","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0540","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/annrheumdis-2017-211480","article-title":"Factors associated with disease progression in early-diagnosed pulmonary arterial hypertension associated with systemic sclerosis: longitudinal data from the DETECT cohort","volume":"77","author":"Mihai","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0545","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/art.40806","article-title":"Casting a spotlight on the right ventricle in systemic sclerosis","volume":"71","author":"Hsu","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0550","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/annrheumdis-2016-210236","article-title":"Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION trial","volume":"76","author":"Coghlan","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0555","doi-asserted-by":"crossref","DOI":"10.1177\/2045893217748307","article-title":"The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study","volume":"8","author":"Sato","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0560","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02493-2016","article-title":"Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertension","volume":"50","author":"Gaine","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0565","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41584-018-0062-0","article-title":"Major lung complications of systemic sclerosis","volume":"14","author":"Denton","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0570","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/art.40815","article-title":"Performance of candidate serum biomarkers for systemic sclerosis \u2013 associated interstitial lung disease","volume":"71","author":"Elhai","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0575","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1002\/art.40130","article-title":"Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis","volume":"69","author":"Goh","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0580","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1136\/annrheumdis-2018-213201","article-title":"Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model","volume":"77","author":"Wu","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0585","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.chest.2017.06.009","article-title":"Mortality risk prediction in scleroderma-related interstitial lung disease: the SADL model","volume":"152","author":"Morisset","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0590","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/S2213-2600(16)30152-7","article-title":"Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial","volume":"4","author":"Tashkin","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0595","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/annrheumdis-2018-214816","article-title":"Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study","volume":"78","author":"Elhai","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0600","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1093\/rheumatology\/key213","article-title":"Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial","volume":"57","author":"Sircar","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0605","first-page":"142","article-title":"Combination therapy with rituximab and mycophenolate mofetil in systemic sclerosis. A single-centre case series study","volume":"36","author":"Fraticelli","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0610","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1016\/S0140-6736(16)00232-4","article-title":"Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial","volume":"387","author":"Khanna","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0615","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/annrheumdis-2017-211682","article-title":"Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate)","volume":"77","author":"Khanna","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0620","article-title":"Efficacy and safety of tocilizumab for the treatment of systemic sclerosis: results from a phase 3 randomized controlled trial","volume":"70","author":"Khanna","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0625","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.3899\/jrheum.151322","article-title":"An open-label phase II Study of the safety and tolerability of pirfenidone in patients with scleroderma-associated interstitial lung disease: the LOTUSS trial","volume":"43","author":"Khanna","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0630","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","article-title":"Nintedanib for systemic sclerosis \u2013 associated interstitial lung disease","volume":"380","author":"Distler","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0635","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13075-018-1517-z","article-title":"Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group","volume":"20","author":"Adler","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0640","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12890-017-0476-5","article-title":"Effectiveness of pulmonary rehabilitation in patients with interstitial lung disease of different etiology: a multicenter prospective study","volume":"17","author":"Tonelli","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0645","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/art.39490","article-title":"Derivation and external validation of a prediction rule for five-year mortality in patients with early diffuse cutaneous systemic sclerosis","volume":"68","author":"Domsic","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0650","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.jacc.2018.07.068","article-title":"Left ventricular diastolic dysfunction predicts mortality in patients with systemic sclerosis","volume":"72","author":"Tenn\u00f8e","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0655","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/rheumatology\/key430","article-title":"Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP","volume":"58","author":"Bissell","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0660","first-page":"882","article-title":"Primary myocardial disease in scleroderma \u2013 a comprehensive review of the literature to inform the UK Systemic Sclerosis Study Grup cardiac working group","volume":"56","author":"Bissell","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0665","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12872-017-0619-x","article-title":"Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria","volume":"17","author":"Mavrogeni","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0670","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/rheumatology\/kew488","article-title":"Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis","volume":"56","author":"Bissell","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0675","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/rheumatology\/kex198","article-title":"Points to consider when doing a trial primarily involving the heart","volume":"56","author":"Allanore","year":"2017","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0680","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/2045893217700438","article-title":"Poor survival in patients with scleroderma and pulmonary hypertension due to heart failure with preserved ejection fraction","volume":"7","author":"Bourji","year":"2017","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0685","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/apt.13963","article-title":"Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis","volume":"45","author":"Kumar","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0690","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/rheumatology\/key350","article-title":"Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality","volume":"58","author":"Richard","year":"2019","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0695","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s13075-018-1694-9","article-title":"T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis","volume":"20","author":"Boleto","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0700","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.autrev.2017.02.008","article-title":"Intravenous immunoglobulins in systemic sclerosis: data from a French nationwide cohort of 46 patients and review of the literature","volume":"16","author":"Sanges","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0705","doi-asserted-by":"crossref","DOI":"10.1007\/s00535-019-01578-6","article-title":"Relationship between esophageal motility abnormalities and skin or lung involvements in patients with systemic sclerosis","author":"Kuribayashi","year":"2019","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0710","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/rheumatology\/key175","article-title":"Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review","volume":"57","author":"Pittman","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2019.05.006","article-title":"A double-blind randomized placebo-controlled trial of probiotics in systemic sclerosis associated gastrointestinal disease","author":"Low","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0720","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13075-017-1340-y","article-title":"Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study","volume":"19","author":"Vigone","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0725","article-title":"Abatacept in early diffuse cutaneous systemic sclerosis \u2013 results of a phase 2 investigator-initiated, multicenter, double-blind randomized placebo-controlled trial","author":"Khanna","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0730","article-title":"Riociguat in patients with early diffuse cutaneous systemic sclerosis: a randomized, double-blind, placebo-controlled phase IIb study (RISE-SSc)","volume":"70","author":"Distler","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0735","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/annrheumdis-2019-eular.6889","article-title":"Efficacy and safety of riociguat in patients with early diffuse cutaneous systemic sclerosis and interstitial lung disease (SSc-ILD): results from the phase IIB rise-ssc study","volume":"78","author":"Distler","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0740","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41584-019-0184-z","article-title":"Emerging targets of disease-modifying therapy for systemic sclerosis","volume":"15","author":"Volkmann","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0745","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0750","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative autologous stem-cell transplantation for severe scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0755","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/bmt.2017.56","article-title":"Cardiopulmonary assessment of patients with systemic sclerosis for hematopoietic stem cell transplantation: recommendations from the European Society for Blood and Marrow Transplantation Autoimmune Diseases Working Party and collaborating partners","volume":"52","author":"Farge","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0760","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.healun.2018.03.003","article-title":"Lung transplantation for scleroderma lung disease: an international, multicenter, observational cohort study","volume":"37","author":"Prad\u00e8re","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0765","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jbspin.2017.09.002","article-title":"Lung transplantation for scleroderma: strength in numbers","volume":"85","author":"Gelber","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0770","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jbspin.2017.03.012","article-title":"Lung transplantation in systemic sclerosis: a single center cohort study","volume":"85","author":"Fern\u00e1ndez-Codina","year":"2018","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0775","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.lpm.2014.01.020","article-title":"Lung and heart-lung transplantation for systemic sclerosis patients. A monocentric experience of 13 patients, review of the literature and position paper of a multidisciplinary Working Group","volume":"43","author":"Launay","year":"2014","journal-title":"Presse Med"},{"key":"10.1016\/j.jbspin.2019.09.015_bib0780","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/rheumatology\/key048","article-title":"Cardiac transplantation in systemic sclerosis: single-centre experience of three cases","volume":"57","author":"Lenaerts","year":"2018","journal-title":"Rheumatology"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19301459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19301459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:26:23Z","timestamp":1761150383000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X19301459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1297319X19301459"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.09.015","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic sclerosis: Recent insight in clinical management","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}